Collegium Pharmaceutical, Inc financial data

Symbol
COLL on Nasdaq
Industry
Pharmaceutical Preparations
Location
100 Technology Center Drive, Stoughton, MA
State of incorporation
VA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 111 % -2.52%
Quick Ratio 7.09 % -11.3%
Debt-to-equity 470 % -12%
Return On Equity 40.8 % +753%
Return On Assets 7.16 % +850%
Operating Margin 32.3 % +50.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 32.3M shares -1.11%
Common Stock, Shares, Outstanding 32.2M shares -2.52%
Entity Public Float 742M USD +23.7%
Common Stock, Value, Issued 40K USD +5.26%
Weighted Average Number of Shares Outstanding, Basic 32.3M shares -4.4%
Weighted Average Number of Shares Outstanding, Diluted 40.2M shares -4.51%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 599M USD +9.62%
Research and Development Expense 7.04M USD -36%
Operating Income (Loss) 193M USD +65.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 128M USD +503%
Income Tax Expense (Benefit) 39.4M USD +223%
Net Income (Loss) Attributable to Parent 88.6M USD +883%
Earnings Per Share, Basic 2.74 USD/shares +915%
Earnings Per Share, Diluted 2.32 USD/shares +1447%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 39M USD -84.9%
Marketable Securities, Current 81M USD +76%
Accounts Receivable, after Allowance for Credit Loss, Current 228M USD +25.6%
Inventory, Net 38M USD +11.4%
Other Assets, Current 93K USD +63.2%
Assets, Current 444M USD -17.4%
Deferred Income Tax Assets, Net 72.5M USD +182%
Property, Plant and Equipment, Net 14.6M USD -12.2%
Operating Lease, Right-of-Use Asset 6.17M USD -1.19%
Intangible Assets, Net (Excluding Goodwill) 947M USD +108%
Goodwill 146M USD +9.04%
Other Assets, Noncurrent 4.17M USD +464%
Assets 1.64B USD +38.9%
Accounts Payable, Current 3.14M USD -14%
Employee-related Liabilities, Current 4.33M USD +360%
Accrued Liabilities, Current 47.6M USD +50.4%
Liabilities, Current 459M USD -1.12%
Contract with Customer, Liability, Noncurrent 10M USD
Deferred Income Tax Liabilities, Net 71.2M USD -24.7%
Operating Lease, Liability, Noncurrent 5.91M USD -7.36%
Liabilities 1.4B USD +40.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax 393K USD
Retained Earnings (Accumulated Deficit) -177M USD +33.4%
Stockholders' Equity Attributable to Parent 234M USD +31%
Liabilities and Equity 1.64B USD +38.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 61.9M USD +124%
Net Cash Provided by (Used in) Financing Activities -54.1M USD -179%
Net Cash Provided by (Used in) Investing Activities -18.1M USD -10200%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 39.6M shares +4.25%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 65M USD -75%
Interest Paid, Excluding Capitalized Interest, Operating Activities 17.5M USD -10.4%
Deferred Tax Assets, Valuation Allowance 5.78M USD +10%
Deferred Tax Assets, Gross 103M USD -16.6%
Operating Lease, Liability 7.11M USD -13.5%
Depreciation 917K USD +12.2%
Payments to Acquire Property, Plant, and Equipment 568K USD +223%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 89M USD -51.9%
Lessee, Operating Lease, Liability, to be Paid 8.49M USD -15.7%
Property, Plant and Equipment, Gross 25.7M USD -0.71%
Operating Lease, Liability, Current 1.27M USD +32%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.44M USD +2.72%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.4M USD -11.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) -4.41M USD -9491%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.38M USD -25.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.47M USD +2.65%
Deferred Tax Assets, Operating Loss Carryforwards 33.8M USD -40.7%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 11.3M USD -0.83%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.49M USD +1.02%
Additional Paid in Capital 583M USD +6.75%
Amortization of Intangible Assets 40.8M USD +12.3%
Deferred Tax Assets, Net of Valuation Allowance 97.4M USD -17.8%
Share-based Payment Arrangement, Expense 31.8M USD +23.3%
Interest Expense 79.3M USD +0.56%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%